key points in differential diagnosis in myasthenic syndromes
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.10/1489 |
Resumo: | Neuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized. |
id |
RCAP_d9de3850a14f204d00b85347127afc83 |
---|---|
oai_identifier_str |
oai:repositorio.hff.min-saude.pt:10400.10/1489 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
key points in differential diagnosis in myasthenic syndromesAspectos fundamentais do diagnóstico diferencial dos sindromas miasténicosCongenital myasthenic syndromesMyasthenia gravisDifferential diagnosisSíndromes miasténicos congénitosMiastenia gravisDiagnóstico diferencialNeuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized.Sociedade Portuguesa de NeurologiaRepositório do Hospital Prof. Doutor Fernando FonsecaMachado, SPires, CManji, H2015-08-17T10:04:37Z2013-01-01T00:00:00Z2013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/1489engSinapse. 2013 Maio;13(1):15-221645-281Xinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:52:15Zoai:repositorio.hff.min-saude.pt:10400.10/1489Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:52:32.837219Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
key points in differential diagnosis in myasthenic syndromes Aspectos fundamentais do diagnóstico diferencial dos sindromas miasténicos |
title |
key points in differential diagnosis in myasthenic syndromes |
spellingShingle |
key points in differential diagnosis in myasthenic syndromes Machado, S Congenital myasthenic syndromes Myasthenia gravis Differential diagnosis Síndromes miasténicos congénitos Miastenia gravis Diagnóstico diferencial |
title_short |
key points in differential diagnosis in myasthenic syndromes |
title_full |
key points in differential diagnosis in myasthenic syndromes |
title_fullStr |
key points in differential diagnosis in myasthenic syndromes |
title_full_unstemmed |
key points in differential diagnosis in myasthenic syndromes |
title_sort |
key points in differential diagnosis in myasthenic syndromes |
author |
Machado, S |
author_facet |
Machado, S Pires, C Manji, H |
author_role |
author |
author2 |
Pires, C Manji, H |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Repositório do Hospital Prof. Doutor Fernando Fonseca |
dc.contributor.author.fl_str_mv |
Machado, S Pires, C Manji, H |
dc.subject.por.fl_str_mv |
Congenital myasthenic syndromes Myasthenia gravis Differential diagnosis Síndromes miasténicos congénitos Miastenia gravis Diagnóstico diferencial |
topic |
Congenital myasthenic syndromes Myasthenia gravis Differential diagnosis Síndromes miasténicos congénitos Miastenia gravis Diagnóstico diferencial |
description |
Neuromuscular junction disorders are a heterogeneous group most often caused by imune or genetic abnormalities. They comprise Myasthenia Gravis, Lambert-Eaton Syndrome and Congenital Myasthenic Syndromes. Despite affecting different parts of the synapse, they share clinical and neurophysiological features, posing a diagnostic challenge. These disorders can be divided in subgroups, according to the causing antibody or genetic defect. However, there are no established clinical criteria and the accurate diagnosis is highly dependent on the recognition of phenotypes. The identification of clues both in the history and examination may be precious to the correct diagnosis. Treatment depends on the underlying abnormality and the prognosis is generally good. However, more severe forms of Myasthenia Gravis and paraneoplastic: Lambert-Eatom Myasthenic Syndrome are recognized. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-01-01T00:00:00Z 2013-01-01T00:00:00Z 2015-08-17T10:04:37Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.10/1489 |
url |
http://hdl.handle.net/10400.10/1489 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Sinapse. 2013 Maio;13(1):15-22 1645-281X |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Neurologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Neurologia |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817550107857387521 |